Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress, and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05245903
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:00.216152+00:00
Published At
2025-11-06T00:00:00+00:00
Record Updated At
2025-11-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Alzheimer Disease", "Dementia Alzheimers", "Dementia", "Cognitive Impairment", "Mild Cognitive Impairment", "Neurodegenerative Diseases", "Neurocognitive Disorders", "Neurocognitive Dysfunction", "Cognitive Dysfunction", "Mental Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-06"
protocolSection.identificationModule.nctId
"NCT05245903"
protocolSection.identificationModule.officialTitle
"Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress, and Cognition in Mild Cognitive Impairment and Mild Alzheimer\u0027s Dementia"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Alzheimer Disease (protocolSection.conditionsModule.conditions)
  • Dementia Alzheimers (protocolSection.conditionsModule.conditions)
  • Dementia (protocolSection.conditionsModule.conditions)
  • Cognitive Impairment (protocolSection.conditionsModule.conditions)
  • Mild Cognitive Impairment (protocolSection.conditionsModule.conditions)
  • Neurodegenerative Diseases (protocolSection.conditionsModule.conditions)
  • Neurocognitive Disorders (protocolSection.conditionsModule.conditions)
  • Neurocognitive Dysfunction (protocolSection.conditionsModule.conditions)
  • Cognitive Dysfunction (protocolSection.conditionsModule.conditions)
  • Mental Disorder (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.